Public Project

From Idea to Approval: How Chelonia Builds Horizon Europe Projects That Deliver Impact Designing a successful Horizon Europe project is...

Bringing Together Regulators, Pharma, and Scientific Leaders to Shape the Future of Antiviral Strategies AVITHRAPID, the cutting-edge...

The path from a scientific discovery to a practical, real-world application is fraught with a myriad of challenges, each requiring a...

Introduction: In the ever-evolving landscape of drug discovery and computational biology, the LIGATE project stands out for its...

In our continuous effort to advance public health, Chelonia Applied Science is a proud participant in the AVITHRAPID project, an...

At Chelonia, we are committed to advancing technology while upholding ethical standards. Our mission aligns with the complex challenges...

We are excited to present AiChemist, an innovative project backed by Horizon Europe and SERI. AiChemist stands at the forefront of...

Chelonia, in collaboration with international partners, has recently submitted a groundbreaking project proposal to the European...

The AVITHRAPID project, running from 2024 to 2029, is part of the European Union's HORIZON-HLTH-2023-DISEASE-03 program. This project...